Literature DB >> 21036495

Fatal poisoning in drug addicts in the Nordic countries in 2007.

K Wiese Simonsen1, P T Normann, G Ceder, E Vuori, S Thordardottir, G Thelander, A C Hansen, B Teige, D Rollmann.   

Abstract

The frequency of medico-legally examined fatal poisonings in 2007 among drug addicts was investigated in five Nordic countries; Denmark, Finland, Iceland, Norway, and Sweden. The number of deaths, age, sex, place of death, main intoxicant, and other drugs present in blood samples were recorded to obtain national and comparable Nordic data, as well as data to compare with earlier studies in 2002, 1997, and 1991. Norway had the highest incidence of drug addict deaths by poisoning followed by Denmark, with 8.24 and 6.92 per 100,000 inhabitants, respectively. The death rates in Finland (4.02), Iceland (4.56), and Sweden (3.53) were about half that of Norway and Denmark. Compared with earlier studies, the death rates were unchanged in Denmark and Norway, but increased in Finland, Iceland, and Sweden. In all countries, fewer deaths (29-35%) were recorded in the capital area compared with earlier studies. Females accounted for 11-19% of the fatal poisonings. Iceland deviates with a more equal distribution between men and women (40%). Deaths from methadone overdoses increased in all Nordic countries, and methadone was the main intoxicant in Denmark in 2007, accounting for 51% of the poisonings. In Norway and Sweden, heroin/morphine was still the main intoxicant with a frequency of 68% and 48%, respectively. In Iceland, 3 deaths each were due to heroin/morphine and methadone, respectively. Finland differs from other Nordic countries in having a high number of poisonings caused by buprenorphine and very few caused by heroin/morphine. The total number of buprenorphine deaths in Finland doubled from 16 in 2002 to 32 in 2007, where it constituted 25% of deaths. The general toxicological screening program showed widespread multi-drug use in all countries. The median number of drugs per case varied from 3 to 5. The most frequently detected substances were heroin/morphine, methadone, buprenorphine, tramadol, amphetamine, cocaine, tetrahydrocannabinol, benzodiazepines and ethanol.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036495     DOI: 10.1016/j.forsciint.2010.10.001

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  15 in total

1.  Effects of d-amphetamine on simulated driving performance before and after sleep deprivation.

Authors:  Magnus Hjälmdahl; Anna Vadeby; Asa Forsman; Carina Fors; Gunnel Ceder; Per Woxler; Robert Kronstrand
Journal:  Psychopharmacology (Berl)       Date:  2012-05-26       Impact factor: 4.530

2.  The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland.

Authors:  Pirkko Kriikku; Janne Rintatalo; Katja Pihlainen; Jukka Hurme; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2015-04-02       Impact factor: 2.686

3.  Carriers of genetic variants in the HNF1A gene are more common among dead opioid addicts than among living addicts.

Authors:  Anh Nguyen; Tore B Stage; Søren Feddersen; Dorte J Christoffersen; Mette Marie H Christensen; Per Damkier; Jørgen L Thomsen; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2016-05-30       Impact factor: 2.953

4.  The Contemporary American Drug Overdose Epidemic in International Perspective.

Authors:  Jessica Y Ho
Journal:  Popul Dev Rev       Date:  2019-02-20

5.  Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning.

Authors:  Margareeta Häkkinen; Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2011-09-17       Impact factor: 2.953

6.  Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers.

Authors:  Sharon L Walsh; Paul A Nuzzo; Shanna Babalonis; Victoria Casselton; Michelle R Lofwall
Journal:  Drug Alcohol Depend       Date:  2016-03-14       Impact factor: 4.492

7.  Quantification of morphine, morphine 6-glucuronide, buprenorphine, and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood.

Authors:  Dorte J Christoffersen; Charlotte Brasch-Andersen; Jørgen L Thomsen; Martin Worm-Leonhard; Per Damkier; Kim Brøsen
Journal:  Forensic Sci Med Pathol       Date:  2015-03-24       Impact factor: 2.007

Review 8.  Buprenorphine Prescribing: To Expand or Not to Expand.

Authors:  Xiaofan Li; Daryl Shorter; Thomas R Kosten
Journal:  J Psychiatr Pract       Date:  2016-05       Impact factor: 1.325

9.  High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study.

Authors:  Bohdan Nosyk; Benedikt Fischer; Huiying Sun; David C Marsh; Thomas Kerr; Juergen T Rehm; Aslam H Anis
Journal:  Am J Addict       Date:  2014 May-Jun

10.  A one-year observational study of all hospitalized acute poisonings in Oslo: complications, treatment and sequelae.

Authors:  Cathrine Lund; Per Drottning; Birgitte Stiksrud; Javad Vahabi; Marianne Lyngra; Ivind Ekeberg; Dag Jacobsen; Knut Erik Hovda
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2012-07-24       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.